Jobs · empllo
Identity and Access Management Engineer (Hybrid)
AbbVie · Worldwide · Posted today
Available in 2 locations
North Chicago, IL, United States · hybrid Apply → Worldwide · hybrid Apply →About the role
📋 Description Deploy, configure, and maintain BeyondTrust Password Safe, Privileged Remote Access, Endpoint Design and implement privileged access policies and workflows aligned with security best practices Configure password vaulting, session recording, and automated password rotation capabilities Integrate BeyondTrust solutions with existing identity management systems, directories, and Monitor system performance, availability, and security of BeyondTrust infrastructure Perform regular system updates, patches, and maintenance activities 🎯 Requirements Bachelors Degree and 6+ years of experience OR Masters Degree and 5+ years of experience OR PhD and Experience with BeyondTrust PAM solutions (Password Safe, Privileged Remote Access, etc.) Strong understanding of privileged access management concepts and security frameworks Experience with Windows and Linux system administration Knowledge of Active Directory, LDAP, and identity management systems Familiarity with database administration (SQL Server, Oracle, MySQL) 🎁 Benefits Medical/dental/vision insurance 401(k) Paid time off (vacation, holidays, sick) Eligibility to participate in short-term incentive programs
Read the full posting on empllo →
FAQ
Is the Identity and Access Management Engineer (Hybrid) role at AbbVie remote?+
This Identity and Access Management Engineer (Hybrid) position is listed as hybrid (Worldwide).
What is the salary for the Identity and Access Management Engineer (Hybrid) role at AbbVie?+
The listing states 96500-183500 USD.
What seniority level is this Identity and Access Management Engineer (Hybrid) role?+
This is a mid level position.
How do I apply for the Identity and Access Management Engineer (Hybrid) role at AbbVie?+
Use the "Apply on empllo" button to open the original posting on empllo, where you can submit your application directly to AbbVie.